The 22nd Phytopharm Congress 2018 was once again a great success: attracting about 275 participants from more than 40 countries. The congress, organized by the St. Petersburg Institute of Pharmacy together with Zurich University of Applied Sciences (ZHAW), took place for the first time in Switzerland. International experts from leading universities and industries presented over 60 lectures and more than a 100 posters to share their latest insights on medicinal plants, natural products and evidence-based phytotherapy. Topics on quality assurance and regulations of herbal medicinal products and food supplements were also covered.
Zeller, as a main supporter of the Phytopharm Congress 2018, made important contributions to this success with talks and poster presentations on new research data. “Research and Development is very important to Zeller. Our products are based on evidence and evidence is based on data”, stated Dr Boonen. Further, Zeller contributed to the congress program with a full-day excursion to the Zeller head offices in Romanshorn and to VitaPlant AG, a subsidiary of Zeller. Under the motto “Zeller World – From Seed to Patient”, 65 congress participants had the opportunity to learn more about the development of evidence-based phyto-pharmaceuticals. In a seminar titled “The Development of a New Herbal Entity” Zeller`s Petasites hybridus extract Ze 339 for the treatment of allergic rhinitis was presented. From controlled plant cultivation through phytochemical analysis, preclinical and clinical studies to drug approval, Zeller demonstrated control of the entire value chain. In the afternoon, the excursion continued at VitaPlant. In a guided tour, the participants were able to see the selected and cultured elite plants in Zeller-VitaPlant’s fields and greenhouses. A highlight was the visit to the medicinal plant garden. “It is very impressive to see Zeller translating the science into something that benefits the society”, says Dr Robert Verpoorte, emeritus professor for Pharmacognosy, University of Leiden.